Jordan R, Midgley J M, Thonoor C M, Williams C M
Research Institute, May & Baker, Ltd., Dagenham, Essex, UK.
J Pharm Pharmacol. 1987 Sep;39(9):752-4. doi: 10.1111/j.2042-7158.1987.tb06986.x.
The activities of the (-)- and (+)-forms of m- and p-octopamine and m- and p-synephrine on beta 1- and beta 2-adrenoceptors in guinea-pig atria and trachea have been compared with that of noradrenaline. The rank order of potency of the (-)-forms on beta 1-adrenoceptors was noradrenaline greater than m-synephrine greater than m-octopamine = p-octopamine greater than p-synephrine. m-Synephrine was 100-fold, m- and p-octopamine about 6000-fold, and p-synephrine about 40,000-fold less active than noradrenaline. The (+)-forms were 1-2 orders of magnitude less active than their (-)-counterparts. The four (-)-compounds were more than four orders of magnitude less active than noradrenaline on beta 2-adrenoceptors, and the (+)-forms had no detectable activity in concentrations as high as 10(-4) M. If m- and p-octopamine are co-released with noradrenaline in amounts proportional to their concentration, their activities at these structures are too low to be physiologically significant.
已将间位和对位去甲辛弗林以及间位和对位辛内弗林的(-)-和(+)-形式对豚鼠心房和气管中β1-和β2-肾上腺素能受体的活性与去甲肾上腺素的活性进行了比较。(-)-形式对β1-肾上腺素能受体的效力排序为:去甲肾上腺素>间位辛内弗林>间位去甲辛弗林 = 对位去甲辛弗林>对位辛内弗林。间位辛内弗林的活性比去甲肾上腺素低100倍,间位和对位去甲辛弗林约低6000倍,对位辛内弗林约低40000倍。(+)-形式的活性比其对应的(-)-形式低1 - 2个数量级。这四种(-)-化合物对β2-肾上腺素能受体的活性比去甲肾上腺素低四个以上数量级,并且(+)-形式在高达10^-4 M的浓度下没有可检测到的活性。如果间位和对位去甲辛弗林与去甲肾上腺素按与其浓度成比例的量共同释放,它们在这些结构上的活性过低,不具有生理意义。